From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

An eight-year-old girl in the U.K. found a life-saving bone marrow donor from across the world just in time for a critical ...

Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated ...

The four compendia comprise Merative Micromedex ® RED BOOK ®, First Databank FDB MedKnowledge ® Drug Pricing, Elsevier Gold Standard Drug Database, and Wolters Kluwer Medi-Span ® Price Rx ®.

Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer ...

Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...

DelveInsight estimates approximately 52K cases of Graft Versus Host Disease in the 7MM. In 2023, the EU4 and the UK recorded ...

A study demonstrates how heart ... Food Insecurity Today, Heart Disease Tomorrow? Mar. 12, 2025 — Struggling to afford food today could mean heart problems tomorrow. Young adults experiencing ...

The following is a summary of “Hematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study,” published in the March 2025 issue of Journal of the ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

A prognosis is made on the basis of the normal course of a disease, the individual's physical and psychological condition, and additional factors such as therapeutic approach.